Michael G. OEFELEIN,Guru V. BETAGERI,Natarajan VENKATESAN
申请号：
US16631566
公开号：
US20200170993A1
申请日:
2018.07.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions and methods for making and using liposomal formulations of paclitaxel are disclosed. The liposomal paclitaxel formulations are used with treatment regimens for bladder cancer and both lower and upper tract urothelial cancer. Hence, the formulations are suitable to treat bladder cancers by intravesical administration and to treat urothelial cancers. The formulations according to the invention include paclitaxel, lecithin, cholesterol, threonine, and glucose.
